Literature DB >> 18401473

Catheter-based local antiproliferative therapy in kissing balloon technique for in-stent stenosis of coronary artery bifurcation lesions.

Christian Herdeg1, Tobias Geisler, Katrin Goehring-Frischholz, Christine Zuern, Ulrike Hartmann, Karl K Haase, Meinrad Gawaz.   

Abstract

There is currently no promising interventional solution for in-stent stenosis in previously stented bifurcation lesions, even with drug-eluting stents. Rather than being restricted to stent struts, catheter-based local antiproliferative therapy offers the advantage of homogenous drug transfer to the whole vessel wall, and thereby allows for intracoronary pharmacotherapy without adding additional layers of metal into an already stented lesion. The newly developed GENIE catheter (Acrostak Corp, Switzerland), applied in the kissing balloon technique, allows for delivery of liquid paclitaxel into whole bifurcation lesions without repeat stent implantation. After conventional percutaneous transluminal coronary angioplasty, local delivery of paclitaxel using two GENIE catheters in the kissing balloon technique was performed in three patients (left anterior descending, left circumflex and right coronary arteries) with highly symptomatic in-stent bifurcation stenoses. The intervention was feasible and safe in all coronary arteries. Final angiography and control angiography after six months showed good results. No major adverse cardiac events occurred 30 days and six months after intervention. The patients, who represent a group at high risk of recurrent instent restenosis, remained asymptomatic since the local drug delivery. They did not require insertion of a drug-eluting stent or crossover to coronary artery bypass surgery. In conclusion, this new treatment strategy proved to be safe and effective in this first human experience and offers a promising alternative to surgery or implantation of additional stents in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18401473      PMCID: PMC2644037          DOI: 10.1016/s0828-282x(08)70182-x

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  7 in total

1.  Visualization and comparison of drug effects after local paclitaxel delivery with different catheter types.

Authors:  C Herdeg; M Oberhoff; A Baumbach; A Blattner; A Küttner; S Schröder; K K Haase; K R Karsch
Journal:  Basic Res Cardiol       Date:  1999-12       Impact factor: 17.165

2.  Bifurcation stenting with drug eluting stents: illustration of the crush technique.

Authors:  Georgios Sianos; Sofia Vaina; Angela Hoye; Patrick W Serruys
Journal:  Catheter Cardiovasc Interv       Date:  2006-06       Impact factor: 2.692

3.  Debating the risks of drug-eluting stents.

Authors:  Miriam Shuchman
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

4.  Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo.

Authors:  C Herdeg; M Oberhoff; A Baumbach; A Blattner; D I Axel; S Schröder; H Heinle; K R Karsch
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

5.  Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

Authors:  D I Axel; W Kunert; C Göggelmann; M Oberhoff; C Herdeg; A Küttner; D H Wild; B R Brehm; R Riessen; G Köveker; K R Karsch
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

Review 6.  Vascular responses to drug eluting stents: importance of delayed healing.

Authors:  Aloke V Finn; Gaku Nakazawa; Michael Joner; Frank D Kolodgie; Erik K Mont; Herman K Gold; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-17       Impact factor: 8.311

7.  Local paclitaxel delivery after coronary stenting in an experimental animal model.

Authors:  Christoph Dommke; Karl K Haase; Tim Süselbeck; Ines Streitner; Dariush Haghi; Jürgen Metz; Martin Borggrefe; Christian Herdeg
Journal:  Thromb Haemost       Date:  2007-09       Impact factor: 5.249

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.